Recent studies into retatrutide, a dual activator for GLP-1 and GIP receptors, are showing encouraging effects in treating obesity and related second-type disease. Animal data suggest a distinct action contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/